Abiomed Inc (ABMD) 123.53 $ABMD ABIOMED Falls 1.77% on

New Post Public Reply Private Reply Replies (0) Message Board

Sep 25, 2016 at 1:19 PM

Abiomed Inc (ABMD) 123.53 $ABMD

ABIOMED Falls 1.77% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Sep 23, 1:55PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $123.06 to a high of $126.09. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $124.43 on volume of 173,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABMD: 123.53 (-2.84)

CryoLife Hits a 52-Week High on Strong Growth Prospects
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 8:25AM CDT
Share price of CryloLife, Inc. (CRY), a leading medical device and tissue processing company, scaled a new 52-week high of $18.64 on Sep 22, eventually closing a bit lower at $18.56.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), IDXX: 111.36 (-1.73), CRY: 18.14 (-0.42)

ABIOMED Has Returned 50.7% Since SmarTrend Recommendation (ABMD)
Comtex SmarTrend(R) - Thu Sep 22, 12:52PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 7 months, ABIOMED has returned 50.65% as of today's recent price of $127.00.
ABMD: 123.53 (-2.84)

Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 6:57AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently closed the acquisition of FEI Company, Inc.
ABMD: 123.53 (-2.84), TMO: 157.66 (unch), CPHD: 52.50 (unch), CRY: 18.14 (-0.42)

Watch for ABIOMED to Potentially Pullback After Gaining 3.39% Yesterday
Comtex SmarTrend(R) - Thu Sep 15, 3:32PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $118.09 to a high of $122.98. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $119.48 on volume of 173,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

40.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Thu Sep 15, 12:23AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.59% as of today's recent price of $118.52.
ABMD: 123.53 (-2.84)

ABIOMED Up 40.3% Since SmarTrend Uptrend Call (ABMD)
Comtex SmarTrend(R) - Wed Sep 07, 1:07PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.30% as of today's recent price of $118.28.
ABMD: 123.53 (-2.84)

Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics
PR Newswire - Thu Aug 18, 7:31AM CDT
Stock-Callers.com is currently focused on the Medical Appliances and Equipment segment, which includes companies that manufacture medical supplies such as surgical and medical instruments, dental equipment, and surgical appliances. According to IBISWorld, global revenue of this industry is about $350 billion. Let us take a look at today's lineup: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Stryker Corp. (NYSE: SYK), ABIOMED Inc. (NASDAQ: ABMD), and The Spectranetics Corp. (NASDAQ: SPNC). Sign up today and download for free the research reports for the stocks covered today at:
SPNC: 24.24 (-0.56), ABMD: 123.53 (-2.84), ZBH: 128.33 (-0.54), SYK: 117.76 (-0.68)

ABIOMED Set to Possibly Pullback After Yesterday's Rally of 2.63%
Comtex SmarTrend(R) - Tue Aug 09, 2:56PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $120.81 to a high of $123.93. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $122.98 on volume of 292,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Mon Aug 08, 12:48PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.
ABMD: 123.53 (-2.84)

Weight Watchers (WTW) Misses Q2 Earnings, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:00AM CDT
Weight Watchers International Inc. (WTW) reported earnings of 46 cents per share, which missed the Zacks Consensus Estimate by 3 cents.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), NTRI: 29.59 (-0.84), WTW: 10.44 (-0.26)

Acadia Healthcare (ACHC) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:34AM CDT
Shares of Acadia Healthcare Company Inc have had a crazy run since the company posted second-quarter 2016 results on Jul 29.
ACHC: 49.54 (-0.78), HCA: 76.12 (-0.26), ABMD: 123.53 (-2.84), WOOF: 67.51 (-2.14)

Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)

SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)

Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)

GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), GNC: 20.15 (-0.20)

Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 123.53 (-2.84)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Acqualina and Back Wellnesswear Launch Eco Lux Collection

An Exclusive Blend of Luxury and Sustainability Picture this: a luxurious oasis on Miami's Sunny Isles Beach, Acqualina Resort, teams up with Back Wellnesswear—the Italian maestros of spa apparel. What do you get? A co-branded clothing collection that screams class, sustainability, and exclusivity, now on the shelves of the Acqualina Spa Boutique. Not your average store...

Ex-Special Ops Leader Fenton Joins SAGINT's Advisory Board

If you’ve been around long enough, you know that in defense, the game’s all about who you know and how you move. And in this arena, General Bryan P. Fenton doesn’t just walk in—he bursts through the darn doors with gravitas honed by years commanding folks who live by grit and sinew. His latest move? Clambering aboard the SAGINT® Board of Advisors, ready to tackle...

Lululemon Faces Lawsuit Over Securities Violations Concerns

Lululemon in Legal Crosshairs So, here's the scoop that's rocking the activewear world. Lululemon athletica inc. (NASDAQ: LULU) is finding itself in hot legal water. The DJS Law Group is sounding the alarm for investors following a securities violation lawsuit slapped on the company. We're talking about some heavy allegations of misleading maneuvers, with accusations...

Navigating Homeowners Insurance Claims: Key Considerations

Deciphering the Homeowners Insurance Jigsaw The modern homeowner doesn't just contend with maintenance and mortgage payments, but also with the labyrinth of insurance policies that promise to shield their homes against calamity. But when the chips are down, is filing an insurance claim always the right call? Sara Turgeon, the insurance maven from Pickens, SC, sheds light...

Securitize's Bold Move: Venturing into Asset-backed Lending

Jumping into the Big League Securitize Corp. is shaking things up with its latest strategic move to acquire River One, an asset-backed financing firm. Now, this ain't just another run-of-the-mill acquisition to throw in the pile—it positions Securitize to plunge into the massive $6 trillion private asset-backed finance market. That's the kind of hefty expansion that...

Deadline Looms for BETR Investors: Take Action Now

What’s the Fuss About? Alright folks, let’s lay this out simple: Better Home & Finance Holding Company (NASDAQ: BETR) is in hot water. A class action’s been slapped on them, accusing the firm of sugarcoating its business prospects. If you bought BETR shares between March 13, 2026, and May 7, 2026, you might have a dog in this fight. Buckle up, because the stakes are...

University of Phoenix Launches 3-Year IT Degree

Introducing the Three-Year IT Degree Pathway Listen up, folks—University of Phoenix is shakin' things up with a new three-year Bachelor's in Information Technology program. This isn't your average run-of-the-mill degree. It's a tailored pathway for IT pros who've been out there in the trenches for at least three years, getting their hands dirty with the tech. Why This...

Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...

NextVision's Q3 2026: Impressive Growth and Expansion

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Rosti Group Expands with Alvi Acquisition

By Ryan Hughes Updated Nov 9, 2026 Category News Views 166

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...